Search Results - "Lindenmaier, Heike"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Comparison of the inhibitory activity of anti-HIV drugs on P-glycoprotein by Storch, Caroline Henrike, Theile, Dirk, Lindenmaier, Heike, Haefeli, Walter Emil, Weiss, Johanna

    Published in Biochemical pharmacology (15-05-2007)
    “…Human immunodeficiency virus 1 (HIV-1) infections are treated with HIV-protease inhibitors (PIs), nucleoside (NRTIs), non-nucleoside (NNRTIs), and nucleotide…”
    Get full text
    Journal Article
  2. 2

    Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors by WEISS, Johanna, THEILE, Dirk, KETABI-KIYANVASH, Nahal, LINDENMAIER, Heike, HAEFELI, Walter Emil

    Published in Drug metabolism and disposition (01-03-2007)
    “…Many drug interactions with drugs used for the therapy of human immunodeficiency virus (HIV) occur at the level of different cytochrome P450 isozymes…”
    Get full text
    Journal Article
  3. 3

    Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells by Troost, Joachim, Lindenmaier, Heike, Haefeli, Walter Emil, Weiss, Johanna

    Published in Molecular pharmacology (01-11-2004)
    “…The drug transporter P-glycoprotein (ABCB1) plays an important role in drug distribution and elimination, and when overexpressed it may confer multidrug…”
    Get more information
    Journal Article
  4. 4

    Interaction of antiepileptic drugs with human P-glycoprotein in vitro by Weiss, Johanna, Kerpen, Christian Johannes, Lindenmaier, Heike, Dormann, Sven-Maria Gregor, Haefeli, Walter Emil

    “…About one-third of epilepsy patients are resistant to treatment with antiepileptic drugs (AEDs). This refractoriness is not fully understood, but is thought to…”
    Get more information
    Journal Article
  5. 5

    INTERACTION OF PROGESTINS WITH THE HUMAN MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2 (MRP2) by LINDENMAIER, Heike, BECKER, Melanie, HAEFELI, Walter Emil, WEISS, Johanna

    Published in Drug metabolism and disposition (01-11-2005)
    “…Progestins are widely used as oral contraceptives and hormone replacement therapy. Recently it has been demonstrated that many progestins are inhibitors of…”
    Get full text
    Journal Article
  6. 6

    Inhibition of the human organic anion transporter 1 by the caffeine metabolite 1-methylxanthine by Rengelshausen, Jens, Lindenmaier, Heike, Cihlar, Tomas, Walter-Sack, Ingeborg, Haefeli, Walter Emil, Weiss, Johanna

    “…Caffeine (1,3,7-trimethylxanthine) is daily and widely consumed in beverages and food and is mainly metabolized to 1,7-dimethylxanthine and 1-methylxanthine…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein by Peters, Tanja, Lindenmaier, Heike, Haefeli, Walter E, Weiss, Johanna

    “…Monastrol is the first characterised small molecule inhibitor of the motor protein Eg5 involved in bipolar mitotic spindle assembly. Eg5 localises to…”
    Get full text
    Journal Article
  9. 9

    Influence of lipid lowering fibrates on P-glycoprotein activity in vitro by Ehrhardt, Manuela, Lindenmaier, Heike, Burhenne, Juergen, Haefeli, Walter Emil, Weiss, Johanna

    Published in Biochemical pharmacology (15-01-2004)
    “…Statin/fibrate combinations are frequently used to treat mixed dyslipidemia. However, these combinations may cause life-threatening drug interactions (e.g…”
    Get full text
    Journal Article
  10. 10

    Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management? by MARTIN-FACKLAM, Meret, RENGELSHAUSEN, Jens, TAYROUZ, Yorki, KETABI-KIYANVASH, Nahal, LINDENMAIER, Heike, SCHNEIDER, Verena, BERGK, Verena, HAEFELI, Walter E

    “…An important information source for pharmacotherapy in populations at risk is drug labelling. We compared the recommendations for patients with renal…”
    Get full text
    Journal Article
  11. 11

    Telomere erosion varies during in vitro aging of normal human fibroblasts from young and adult donors by FIGUEROA, R, LINDENMAIER, H, HERGENHAHN, M, NIELSEN, K. V, BOUKAMP, P

    Published in Cancer research (Chicago, Ill.) (01-06-2000)
    “…The life span of normal fibroblasts in vitro (Hayflick limit) depends on donor age, and telomere shortening has been proposed as a potential mechanism. By…”
    Get full text
    Journal Article